Sharp Invests More into Enhancing IRT Solution

February 6, 2019

Applied Clinical Trials

Sharp-part of UDG Healthcare plc, a global company in contract packaging and clinical supply services-announced that it is investing $650,000 into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots, and investigative sites.

To read the full release, click here.

 

 

 

Related Content:

News